Dr. Parikh’s area of focus is benign prostatic hyperplasia (BPH), prostate cancer and kidney cancer as well as primary and secondary liver cancer. As a widely recognized expert on the utilization of prostate artery embolization (PAE) for the management of patients with prostate cancer, Dr. Parikh is dedicated to advancing innovative oncologic care and founded the PAE program at Moffitt Cancer Center in 2017. He has also published several manuscripts on the topic and currently serves as the primary investigator for a clinical trial studying the role of neoadjuvant PAE prior to definitive radiotherapy for men with prostate cancer (https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-2083…). Dr. Parikh has also served in several leadership roles for Moffitt Cancer Center and is currently the Vice President, Chief Clinical Expansion and Partnership Officer. In this role he focuses on clinical growth initiatives and partnerships that bring MoffittCare to the community, closer to patients' homes. He previously served as Assistant Chief Medical Officer with a focus on finance, strategy and digital innovation. Dr. Parikh earned his undergraduate degree from Columbia University in NYC and subsequently worked as an investment banker on Wall Street. Determined to make a significant impact on the daily lives of patients, he obtained MD and MBA degrees from Tufts University School of Medicine in Boston, MA. He then completed diagnostic radiology residency at NYU Medical Center in New York City, before moving back to Boston to complete a fellowship in Angiography and Interventional Radiology at the Brigham and Women’s Hospital – Harvard Medical School.